Over 100 members of staff from PwC Midlands are lacing their running shoes and donning their pink running tops to represent national blood cancer charity, Cure Leukaemia, in this May’s Great Birmingham Run.

Taking place on King Charles’ Coronation Weekend, the charity are looking to field their biggest ever team of runners in both the half marathon and 10k events, on Sunday 7th May as they bid to turn Birmingham pink!

Money raised by employees will be invested in the national Trials Acceleration Programme (TAP) which has been solely funded by Cure Leukaemia since 2020. The TAP Network is a network of specialist research nurses at 15 blood cancer centres located in the UK’s biggest cities. This network enables accelerated setup and delivery of potentially life-saving blood cancer clinical trials to run, giving patients from a UK catchment area of over 20 million people access to treatments not currently available through standard care.

Neil Philpott, Audit Partner at PwC Midlands, said:

“We’ve taken part in the Great Birmingham Run for many years now, and it’s great to see over 100 members of staff from our Birmingham, Donington Court and Milton Keynes offices signing up to take on the challenge again this year. We’re committed to supporting local causes through our Place & Purpose strategy and it’s great to be able to do something positive for staff physical and mental wellbeing too. I want to wish good luck to everyone taking part and I’m proud that so many PwC colleagues are turning out to raise money for Cure Leukaemia.”


Cure Leukaemia Chief Executive James McLaughlin will be running alongside the team on the day as he tackles the Half Marathon and he was delighted to have PwC as part of Team CL.


“We are so grateful that the team at PwC have chosen to fundraise and run on behalf of Cure Leukaemia at this year’s Great Birmingham Run. The organisation have been longstanding supporters of the charity over the years and have entered several Cure Leukaemia events and raise important funds for blood cancer patients across the UK, and I would like to thank them on behalf of our patients”